v3.26.1
Parent Only Financial Statements (Tables)
12 Months Ended
Mar. 31, 2026
Parent Only Financial Statements [Abstract]  
Schedule of Condensed Balance Sheets
    As of March 31,  
    2026     2025  
  US$     US$  
ASSETS            
Current Assets:            
Cash and cash equivalents     3,737,770       —  
Deposits, prepayments and other receivables, net     1,364,434       —  
Investment in funds     1,326,000       —  
Amount due from subsidiaries     —       108,835  
Total current assets     6,428,204       108,835  
Non-current assets:                
Investment in a subsidiary     500       500  
Deposits, prepayments and other receivables, net     180,000       —  
Deferred offering costs     —       545,359  
Total non-current assets     180,500       545,859  
Total assets     6,608,704       654,694  
LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)                
Current liabilities:                
Accruals     158,391       25,000  
Amount due to a shareholder     768,390       1,064,828  
Amounts due to subsidiaries     2,341,579       —  
Total current liabilities     3,268,360       1,089,828  
TOTAL LIABILITIES     3,268,360       1,089,828  
             
Commitments and contingencies (Note 15)            
             
Shareholders’ equity (deficit)            
Class B Ordinary shares, US$0.0001 par value, 15,000,000 shares authorized, and 2,000,000 shares issued and outstanding as of March 31, 2026 and 2025, respectively     200       200  
Class A Ordinary shares, US$0.0001 par value, 60,000,000 shares authorized, and 15,178,000 and 13,338,000 shares issued and outstanding as of March 31, 2026 and 2025, respectively     1,518       1,334  
Additional paid-in capital     4,784,361       —  
Subscription receivables     —       (1,534 )
Accumulated losses     (1,445,735 )     (435,134 )
Total shareholders’ equity (deficit)     3,340,344       (435,134 )
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)     6,608,704       654,694  
Schedule of Condensed Statements of Operations
    Years ended March 31,  
    2026     2025     2024  
    US$     US$     US$  
OTHER INCOME (EXPENSES)                  
Interest income     26,899       —       —  
Unrealized gain from investment in funds     26,000       —       —  
Other expenses     (1,512 )     —       —  
      51,387       —       —  
                         
OPERATING COST AND EXPENSES                        
Staff costs and employee benefits     (92,219 )     —       —  
Advertising and promotion expenses     (101,832 )     —       —  
Professional expenses     (772,554 )     (185,134 )     (250,000 )
Bank charges     (890 )     —       —  
Other general and administrative expenses     (94,493 )     —       —  
      (1,061,988 )     (185,134 )    

(250,000

)
LOSS BEFORE INCOME TAX EXPENSES     (1,010,601 )     (185,134 )     (250,000 )
Income tax expenses     —       —       —  
NET LOSS     (1,010,601 )     (185,134 )     (250,000 )
Schedule of Condensed Statements of Cash Flows
    Year ended March 31,  
    2026     2025     2024  
    US$     US$     US$  
CASH FLOWS FROM OPERATING ACTIVITIES:                  
Net loss     (1,010,601 )     (185,134 )     (250,000 )
Adjustments to reconcile net loss to net cash used in operating activities                        
Unrealized gain from investment in funds     (26,000 )     —       —  
Changes in operating assets and liabilities                        
Deposits, other receivables and prepayments     (1,544,434 )     —       —  
Accruals and other payables     133,391       (225,000 )     250,000  
Net cash used in operating activities     (2,447,644 )     (410,134 )     —  
                         
CASH FLOWS FROM INVESTING ACTIVITIES:                        
Investment in funds     (1,300,000 )     —       —  
Repayment from subsidiaries     108,835       —       —  
Advances to subsidiaries     —       (109,335 )     —  
Net cash used in investing activities     (1,191,165 )     (109,335 )     —  
                         
CASH FLOWS FROM FINANCING ACTIVITIES:                        
Payments of offering costs related to IPO     (1,176,763 )     (545,359 )     —  
Proceeds from issuance of shares pursuant to IPO from underwriters     6,533,660       —       —  
Advances from subsidiaries     2,314,586       —       —  
Advance from a director     —       1,064,828       —  
Repayment to a director     (294,904 )     —       —  
Net cash provided by financing activities     7,376,579       519,469       —  
NET CHANGE IN CASH AND CASH EQUIVALENTS     3,737,770       —       —  
CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE YEAR     —       —       —  
CASH AND CASH EQUIVALENTS AT THE END OF THE YEAR     3,737,770       —       —